Intraindividual response to treatment with pirfenidone in idiopathic pulmonary fibrosis

Am J Respir Crit Care Med. 2015 Jan 1;191(1):110-3. doi: 10.1164/rccm.201406-1106LE.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Aged
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Antifibrinolytic Agents / administration & dosage
  • Antifibrinolytic Agents / adverse effects
  • Antifibrinolytic Agents / therapeutic use
  • Female
  • Germany
  • Humans
  • Idiopathic Pulmonary Fibrosis / drug therapy*
  • Italy
  • Male
  • Middle Aged
  • Pyridones / administration & dosage
  • Pyridones / adverse effects
  • Pyridones / therapeutic use*
  • Retrospective Studies
  • Total Lung Capacity / drug effects
  • Treatment Outcome
  • Vital Capacity / drug effects

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antifibrinolytic Agents
  • Pyridones
  • pirfenidone